“Efficacy of Tildrakizumab 200 Mg for Treating Difficult-to-Treat Patient Populations With Moderate-to-Severe Plaque Psoriasis”. Dermatology Reports 17, no. 1 (August 9, 2024). Accessed June 19, 2025. https://journals.pagepress.org/dr/article/view/9999.